A complementary research was conducted to explore the outcome of hybrid 83c on inhibiting tubulin polymerization and figure out its potential to control microtubule dynamics in residing cells [forty nine]. The immunofluorescence assay was done utilizing the HT29 mobile line, with colchicine and paclitaxel as constructive Management drugs (Figure 28